US4448632038 - Common Stock
HUMANIGEN INC
NASDAQ:HGEN (7/25/2023, 7:00:02 PM)
After market: 0.0358 0 (-0.83%)0.0361
-0.16 (-81.12%)
Humanigen, Inc. is a clinical-stage biopharmaceutical company. The company is headquartered in Short Hills, New Jersey and currently employs 6 full-time employees. The company went IPO on 2013-01-30. The firm is engaged in developing its portfolio of proprietary Humaneered anti-inflammatory immunology and immuno-oncology monoclonal antibodies. Its Humaneered technology platform is a method for converting existing antibodies (typically murine) into engineered, high-affinity human antibodies designed for therapeutic use, particularly with acute and chronic conditions. Its product candidate, lenzilumab, and its other product candidate, ifabotuzumab (iFab), are Humaneered monoclonal antibodies are Humaneered monoclonal antibodies. lenzilumab is used as a therapeutic for chronic myelomonocytic leukemia; for the prevention of acute graft versus host disease; and as a prophylactic companion for certain chimeric antigen receptor therapy (CAR-T) programs. The firm has developed or in-licensed targets or research antibodies, typically from academic institutions, and then applied its Humaneered technology to optimize them.
HUMANIGEN INC
830 Morris Turnpike, 4th Floor
Short Hills NEW JERSEY 94010
P: 19732003100.0
CEO: Cameron Durrant
Employees: 6
Website: https://www.humanigen.com/
Humanigen stock is falling hard on Friday as investors in HGEN sell shares after the company announced a bankruptcy filing.
The RATinG (Risk Adapted Therapy in Acute GvHD) is the first trial to explore granulocyte-macrophage colony-stimulating factor (GM-CSF) neutralization for...
Biogen (BIIB) layoffs are on the way as the company seeks further profits with its upcoming Alzheimer's disease drug launch.
Bellerophon Therapeutics (BLPH) stock is losing value on Tuesday after the clinical-stage therapeutics company was sent a delisting notice.
Humanigen (HGEN) stock is falling hard on Tuesday after the company warned investors it can't keep listing requirements.
It's time for another dive into the biggest pre-market stock movers as we check out the most recent news for Tuesday morning!
Here you can normally see the latest stock twits on HGEN, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.
Example Twits: